or Try an Advanced Search...

    Targeted Therapy Stocks List

    Symbol Grade Name % Change
    AVTX C Avalo Therapeutics, Inc. -5.96
    ATRA D Atara Biotherapeutics, Inc. -4.59
    APLM D Apollomics Inc. -24.30
    CRDF D Cardiff Oncology, Inc. 2.17
    POAI D Predictive Oncology Inc. 2.21
    CELC F Celcuity Inc. 0.86
    BCAB F BioAtla, Inc. -3.78
    TCON F TRACON Pharmaceuticals, Inc. -31.40
    IDYA F IDEAYA Biosciences, Inc. 1.43
    OLMA F Olema Pharmaceuticals, Inc. -2.66
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Medical Instruments & Supplies
    Related Stock Lists: Medicine Clinical Medicine Cancer Biopharmaceutical Drugs Biomarkers Biotechnology Oncology Precision Medicine Acute Myeloid Leukemia Antineoplastic Drugs Biology Breast Cancer Cancer Immunotherapy Cell Biology Chemotherapy Clinical Development Colorectal Cancer Hepatocellular Carcinoma Leukemia

    Related ETFs - A few ETFs which own one or more of the above listed Targeted Therapy stocks.

    Symbol Grade Name Weight
    SBIO C ALPS Medical Breakthroughs ETF 2.24
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 1.94
    JFWD B Jacob Funds Inc. Jacob Forward ETF 1.74
    CNCR F Loncar Cancer Immunotherapy ETF 1.07
    CANC D Tema Oncology ETF 0.9
    View all Targeted Therapy ETFs...
    Compare ETFs
    Compare BBC to CNCR Compare BBC to JFWD Compare JFWD to CNCR

        Targeted Therapy Stocks Recent News

        Date Stock Title
        Nov 19 CRDF Cardiff Oncology Announces New Patent with Claims for the Use of Onvansertib in Treating KRAS mutated mCRC
        Nov 18 IDYA IDEAYA Biosciences Appoints Stu Dorman as Chief Commercial Officer
        Nov 15 IDYA Jim Cramer Says This Tobacco Stock Is 'Undervalued' But He's Not Recommending It
        Nov 15 POAI Predictive Oncology Third Quarter 2024 Earnings: Misses Expectations
        Nov 15 CELC Celcuity Inc (CELC) Q3 2024 Earnings Call Highlights: Clinical Milestones and Financial Challenges
        Nov 15 CELC Celcuity Inc. (CELC) Q3 2024 Earnings Call Transcript
        Nov 14 CELC Celcuity GAAP EPS of -$0.70 misses by $0.05
        Nov 14 CELC Celcuity Inc. Reports Third Quarter Financial Results and Provides Corporate Update
        Nov 14 BCAB Michael Burry's Scion fund exits BioAtla, boosts Alibaba stake, adds puts: top Q3 trades
        Related Industries: Biotechnology Diagnostics & Research Medical Instruments & Supplies
        Related Stock Lists: Medicine Clinical Medicine Cancer Biopharmaceutical Drugs Biomarkers Biotechnology Oncology Precision Medicine Acute Myeloid Leukemia Antineoplastic Drugs Biology Breast Cancer Cancer Immunotherapy Cell Biology Chemotherapy Clinical Development Colorectal Cancer Hepatocellular Carcinoma Leukemia
        Targeted Therapy

        Targeted therapy is a type of cancer treatment that uses drugs or other substances to identify and attack specific cancer cells without harming normal cells. It works by targeting the molecules and pathways that are involved in the growth and spread of cancer cells. Targeted therapy is used to treat many types of cancer, including breast, lung, and colorectal cancer.

        Browse All Tags